Market Cap 1.26B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 4,302,522
Avg Vol 3,975,320
Day's Range N/A - N/A
Shares Out 303.16M
Stochastic %K 10%
Beta 0.85
Analysts Strong Sell
Price Target $9.50

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
DeMampCamp
DeMampCamp Apr. 30 at 4:43 PM
$ABCL How many short timers did we flush out yesterday? Great rebound so far!
1 · Reply
TradeWinner
TradeWinner Apr. 30 at 3:53 PM
$ABCL and back to our regularly scheduled program.
0 · Reply
Rastafari
Rastafari Apr. 30 at 3:33 PM
$ABCL Thank you Carl!
1 · Reply
SuperGreenToday
SuperGreenToday Apr. 30 at 3:15 PM
$ABCL Share Price: $3.94 Contract Selected: Oct 16, 2026 $5 Calls Buy Zone: $0.21 – $0.26 Target Zone: $0.37 – $0.46 Potential Upside: 66% ROI Time to Expiration: 168 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
capitalthinktank
capitalthinktank Apr. 30 at 3:00 PM
$ABCL on the monthly timeframe continues to present a structurally bullish long-term setup. The key macro pivot remains the $4.70 level, which acts as the primary threshold for maintaining the broader bullish structure. Price recently approached this zone but has not yet confirmed a decisive breakout beyond it. Volume activity is beginning to re-accelerate after a period of compression, suggesting renewed participation is entering the name. This type of volume expansion at a major monthly resistance area is often critical for trend continuation or breakout validation. As long as price holds above the broader support structure and continues building acceptance near this zone, the long-term technical picture remains constructive. A sustained move and close above $4.70 would further strengthen the breakout thesis and open the door for continuation of the higher timeframe uptrend. Overall, the monthly structure remains intact with improving participation dynamics and a key level now in focus.
0 · Reply
tradersunion353
tradersunion353 Apr. 30 at 1:56 PM
$ABCL Who are these clowns pumping this POS performance Overhyped and underperforming junk Who cares what science they if they are not benefittong investors.. Most of the folks here just married are married. espiecally that Dem guy
0 · Reply
JennyRowes
JennyRowes Apr. 30 at 12:59 PM
$ABCL shareholder letter totally worth reading https://d18rn0p25nwr6d.cloudfront.net/CIK-0001703057/a3205993-6fb1-4f79-8fcb-7863eccb246f.pdf
1 · Reply
DragonAlgo
DragonAlgo Apr. 30 at 3:52 AM
🐉 $ABCL PUT — DragonAlgo® Signal Contract: ABCL PUT Expiry: 2026-10-16 | Strike: $8.00 | Type: PUT Option Plan (premium): Entry: $4.30 Stop: $3.10 TP1: $5.59 TP2: $7.31 TP3: $10.32 🔗 https://dragonalgo.com
0 · Reply
Arcides
Arcides Apr. 29 at 11:38 PM
$ABCL 5 consecutive days with a lot of volume, this is being dumped again.
1 · Reply
UncleTomFlorida
UncleTomFlorida Apr. 29 at 11:33 PM
$ABCL 1, 5, 10 yr price targets courtesy of Probabli.xyz Free A.I.
0 · Reply
Latest News on ABCL
AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 2 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 2 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 6 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 6 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 8 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 9 months ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


AbCellera Announces Resignation of Board Member

Feb 23, 2024, 4:30 PM EST - 2 years ago

AbCellera Announces Resignation of Board Member


AbCellera Biologics Earnings Call Transcript: Q4 2023

Feb 20, 2024, 5:00 PM EST - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q4 2023


AbCellera Biologics Earnings Call Transcript: Q3 2023

Nov 2, 2023, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q3 2023


AbCellera Biologics Earnings Call Transcript: Q2 2023

Aug 3, 2023, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2023


AbCellera Biologics Earnings Call Transcript: Q1 2023

May 4, 2023, 5:00 PM EDT - 3 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2023


AbCellera Biologics Earnings Call Transcript: Q4 2022

Feb 21, 2023, 5:00 PM EST - 3 years ago

AbCellera Biologics Earnings Call Transcript: Q4 2022


AbCellera Biologics Transcript: JPMorgan Healthcare Conference

Jan 11, 2023, 5:15 PM EST - 3 years ago

AbCellera Biologics Transcript: JPMorgan Healthcare Conference


AbCellera Biologics Earnings Call Transcript: Q3 2022

Nov 8, 2022, 5:00 PM EST - 3 years ago

AbCellera Biologics Earnings Call Transcript: Q3 2022


AbCellera Biologics Earnings Call Transcript: Q2 2022

Aug 9, 2022, 5:00 PM EDT - 4 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2022


AbCellera Biologics Earnings Call Transcript: Q1 2022

May 10, 2022, 8:52 AM EDT - 4 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2022


AbCellera Biologics Earnings Call Transcript: Q4 2021

Feb 24, 2022, 9:23 AM EST - 4 years ago

AbCellera Biologics Earnings Call Transcript: Q4 2021


AbCellera Biologics Earnings Call Transcript: Q3 2021

Nov 8, 2021, 7:00 PM EST - 4 years ago

AbCellera Biologics Earnings Call Transcript: Q3 2021


AbCellera Biologics Earnings Call Transcript: Q2 2021

Aug 12, 2021, 12:02 PM EDT - 5 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2021


AbCellera Biologics Earnings Call Transcript: Q1 2021

May 13, 2021, 9:46 AM EDT - 5 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2021


AbCellera Biologics Earnings Call Transcript: Q4 2020

Mar 29, 2021, 9:46 AM EDT - 5 years ago

AbCellera Biologics Earnings Call Transcript: Q4 2020


DeMampCamp
DeMampCamp Apr. 30 at 4:43 PM
$ABCL How many short timers did we flush out yesterday? Great rebound so far!
1 · Reply
TradeWinner
TradeWinner Apr. 30 at 3:53 PM
$ABCL and back to our regularly scheduled program.
0 · Reply
Rastafari
Rastafari Apr. 30 at 3:33 PM
$ABCL Thank you Carl!
1 · Reply
SuperGreenToday
SuperGreenToday Apr. 30 at 3:15 PM
$ABCL Share Price: $3.94 Contract Selected: Oct 16, 2026 $5 Calls Buy Zone: $0.21 – $0.26 Target Zone: $0.37 – $0.46 Potential Upside: 66% ROI Time to Expiration: 168 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
capitalthinktank
capitalthinktank Apr. 30 at 3:00 PM
$ABCL on the monthly timeframe continues to present a structurally bullish long-term setup. The key macro pivot remains the $4.70 level, which acts as the primary threshold for maintaining the broader bullish structure. Price recently approached this zone but has not yet confirmed a decisive breakout beyond it. Volume activity is beginning to re-accelerate after a period of compression, suggesting renewed participation is entering the name. This type of volume expansion at a major monthly resistance area is often critical for trend continuation or breakout validation. As long as price holds above the broader support structure and continues building acceptance near this zone, the long-term technical picture remains constructive. A sustained move and close above $4.70 would further strengthen the breakout thesis and open the door for continuation of the higher timeframe uptrend. Overall, the monthly structure remains intact with improving participation dynamics and a key level now in focus.
0 · Reply
tradersunion353
tradersunion353 Apr. 30 at 1:56 PM
$ABCL Who are these clowns pumping this POS performance Overhyped and underperforming junk Who cares what science they if they are not benefittong investors.. Most of the folks here just married are married. espiecally that Dem guy
0 · Reply
JennyRowes
JennyRowes Apr. 30 at 12:59 PM
$ABCL shareholder letter totally worth reading https://d18rn0p25nwr6d.cloudfront.net/CIK-0001703057/a3205993-6fb1-4f79-8fcb-7863eccb246f.pdf
1 · Reply
DragonAlgo
DragonAlgo Apr. 30 at 3:52 AM
🐉 $ABCL PUT — DragonAlgo® Signal Contract: ABCL PUT Expiry: 2026-10-16 | Strike: $8.00 | Type: PUT Option Plan (premium): Entry: $4.30 Stop: $3.10 TP1: $5.59 TP2: $7.31 TP3: $10.32 🔗 https://dragonalgo.com
0 · Reply
Arcides
Arcides Apr. 29 at 11:38 PM
$ABCL 5 consecutive days with a lot of volume, this is being dumped again.
1 · Reply
UncleTomFlorida
UncleTomFlorida Apr. 29 at 11:33 PM
$ABCL 1, 5, 10 yr price targets courtesy of Probabli.xyz Free A.I.
0 · Reply
DeMampCamp
DeMampCamp Apr. 29 at 11:07 PM
$ABCL If you haven't had a chance to read the annual shareholder report, take some time to do so! This is the type of transparency and I've been yearning for throughout the years, but better late than never! Nasty day here, but without rain there's no rainbow! Chin up, folks, tomorrow's a new day!
1 · Reply
UncleTomFlorida
UncleTomFlorida Apr. 29 at 11:04 PM
0 · Reply
Rastafari
Rastafari Apr. 29 at 10:40 PM
$ABCL what a letter! Glad I added today!
0 · Reply
8008track
8008track Apr. 29 at 9:43 PM
$ABCL Carl Hansen is a long term thinker. If he gets this right, and he intends to, this will go down as an easy 10x. If they crush it, then I could see this being a 100-200x from here. It won’t happen overnight and will take another 10-20 years but it’s definitely possible. Good luck to all the longs!
2 · Reply
8008track
8008track Apr. 29 at 9:19 PM
$ABCL annual report: https://d18rn0p25nwr6d.cloudfront.net/CIK-0001703057/a3205993-6fb1-4f79-8fcb-7863eccb246f.pdf
0 · Reply
Rastafari
Rastafari Apr. 29 at 9:14 PM
$ABCL https://x.com/jackprescottx/status/2049590390089830747?s=12
0 · Reply
tradersunion353
tradersunion353 Apr. 29 at 8:22 PM
$ABCL Overhyped underperforming jubk dropped 9% with 3x more volume .., something is defineltly fishy Dont fall for that DEMAMP pumper he has been pumping POS for years... he comes up with new BS every time when stock crashes
0 · Reply
TradeWinner
TradeWinner Apr. 29 at 8:00 PM
$ABCL ho hum. May 11th will be here soon.
0 · Reply
LongTermInvestingCKramer
LongTermInvestingCKramer Apr. 29 at 7:56 PM
$ABCL Level of panic mode here is ridiculous. phase 1 is long complete and results are great (listen to CFO prestation for your reference) and phase 2 results are only due Q3 of this year. this drop is purely technical, couldn't break through the 200day MA and got heavily shorted (result: cheap shares for others).
0 · Reply
8008track
8008track Apr. 29 at 7:52 PM
$ABCL I picked up a few more $5 lotto calls that expire in a couple of weeks. All other shares are held long term regardless of what happens on earnings call.
0 · Reply
UncleTomFlorida
UncleTomFlorida Apr. 29 at 7:43 PM
$ABCL https://d18rn0p25nwr6d.cloudfront.net/CIK-0001703057/a3205993-6fb1-4f79-8fcb-7863eccb246f.pdf
0 · Reply
8008track
8008track Apr. 29 at 7:19 PM
$ABCL yawn…. wake me up when we hit $40
0 · Reply